Siegfried Holding

Update in progress

SFZN.SW (Swiss)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Siegfried Holding AG, with its subsidiaries, focuses on contract development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms worldwide. It offers custom API synthesis, a broad API portfolio (exclusive and non-exclusive), and pharma-grade substances for anesthetics, pain and addiction, CNS, respiratory, and caffeine-related uses. It also provides drug products (sterile fill/finish, ophthalmics, inhalation, oral solids), viral vectors, and tech services in chemistry, analytics, formulation, containment, and cell/gene therapies. Founded 1873; based in Zofingen, Switzerland.

Company score

Sentiment: 0.25; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.13; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.07; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.15; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive